Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial

Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-04-24T16:45:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:34:29.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T22:10:30.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:14:01.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page shows an updated revision label: v3.4.2 replaces the previous v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:08:58.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    A minor revision tag was updated from v3.4.0 to v3.4.1 on the page, with no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:28:57.000Z thumbnail image

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.